InsidersTradesSigma
셀바이오휴먼텍: insider trades · South Korea · DART (FSS)
DART:company-6a6240KR·DART (FSS)Mcap 66.6Bn€
Discover the full insider trade history of 셀바이오휴먼텍, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €66.6bn. The latest transaction was reported on 7 April 2026 — Purchase. Among the most active insiders: 이권선. All data is accessible without an account.
3
Insider Decl.
0
Thresholds
€63,266
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
6120.00 €
Income statement
Revenue51.07 Bn€
Gross profit18.85 Bn€37% margin
Net income8.72 Bn€17.1% margin
Balance sheet & cash
Market cap66.58 Bn€
Total debt20.51 Bn€
Free Cash Flow−5.32 Bn€
Last declaration on 7 April 2026
Declarations3 total
3 of 3 declarations